Hyperemesis gravidarum pathophysiology
Hyperemesis gravidarum Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hyperemesis gravidarum pathophysiology On the Web |
American Roentgen Ray Society Images of Hyperemesis gravidarum pathophysiology |
Risk calculators and risk factors for Hyperemesis gravidarum pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Template:MAzhar
Overview
Development of hyperemesis gravidarum is the result from multiple genetic mutations. Hyperemesis gravidarum usually develops during the 2nd trimester of pregnancy.
The pathophysiology of nausea and vomiting during pregnancy is not entirely understood. It is believed to be associated with human chorionic gonadotropin (hCG), a hormone produced by the placenta during pregnancy [5].
Pathogenesis
The pathophysiology of nausea and vomiting during pregnancy is not entirely understood. It is believed to be associated with [human chorionic gonadotropin (hCG)], a hormone produced by the placenta during pregnancy [5].
According to most studies, it is believed to be multifactorial and related to some genetic, endocrine and gastrointestinal factors.
- Genetic:
- More commonly associated with female [monozygotic twins]
- Higher risk in patients whose mothers had HG
- Higher risk among patients that had history of HG in their first pregnancy
- Endocrine:
- hCG, estrogen and progesterone are linked to nausea and vomiting in pregnancy
- Human Chorionic Gonadotropin hormone:
- Peaks at weeks 9-12, which correlates with an increased severity of nausea and vomiting during pregnancy, as well as the symptoms of hyperemesis gravidarum.
- The concentration of hCG in the blood and urine is found to be higher among patients with worsened symptoms of HG.
Genetics
- Hyperemesis gravidarum is transmitted in dominant pattern.
- Gene 1B-alpha2Y is highly associated with hyperemesis gravidarum and twin pregnancies.
Associated Conditions
The most important conditions associated with hyperemesis gravidarum include: